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Numerous clinical reports underscore the frequency of olfactory impairments in patients suffering from major depressive disorders
(MDDs), yet the underlying physiopathological mechanisms remain poorly understood. We hypothesized that one key link between
olfactory deficits and MDD lies in hypercortisolemia, a cardinal symptom of MDD. Corticosterone (CORT) is known to negatively
correlatewith hippocampal neurogenesis, yet its effects on olfactory neurogenesis and olfaction remain unknown.Herewe used a rodent
model of anxiety/depression-like states, which is based on chronic CORT administration and studied the effects of the antidepressant
fluoxetine (FLX) on behavior, olfaction, and adult neurogenesis in the dentate gyrus (DG), olfactory bulb (OB), and the olfactory epithe-
lium (OE). Chronic CORT had no effect on cell proliferation in the OE or on olfactory sensory neurons projecting to the OB, but induced
pronounced deficits in olfactory acuity, fine discrimination of odorants and olfactorymemory. These alterations were accompanied by a
significant decrease in the number of adult-born neurons in both the DG and OB. Remarkably, FLX not only reversed depression-like
states as expected, but also improved olfactory acuity, memory, and restored impaired adult neurogenesis. However, fine olfactory
discrimination was not restored. Morphological analysis of adult-born neurons in both the DG and the OB showed that dendritic
complexity was not significantly affected by CORT, but was increased by FLX. These findings demonstrate an essential role for glucocor-
ticoids in triggering olfactory impairments in MDD and highlight a novel therapeutic effect of FLX.
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Introduction
Major depressive disorders (MDDs) are highly prevalent and de-
bilitating conditions, whose pathophysiological mechanisms and
response to treatments remain poorly understood (Krishnan and
Nestler, 2008). Increasing clinical reports underscore the fre-
quency of olfactory impairments in patients suffering from
MDDs (Pause et al., 2001; Negoias et al., 2010), yet, it remains
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Significance Statement
Increasing clinical reports show that major depression is characterized by pronounced olfactory deficits, yet the underlying
mechanisms remain unknown. In this work, we used an endocrinemodel of depression to studywhether hypothalamic-pituitary-
adrenal axis perturbation could be sufficient to provoke olfactory impairments. We found that chronic corticosterone not only
inducesmarked deficits in olfactory acuity, fine discrimination and olfactorymemory, but also significantly decreases bulbar and
hippocampal neurogenesis. Importantly, the antidepressant fluoxetine restores both adult neurogenesis and depressive states,
and improves most olfactory functions. Our data reveal that impairment of hypothalamic-pituitary-adrenal axis during depres-
sion can lead to olfactory deficits and that the neurogenic effects of selective serotonin reuptake inhibitor antidepressants can
successfully restore certain olfactory functions.
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unclear how mood states and olfactory processes interact in psy-
chiatric disorders such as MDDs.
Olfactory deficits in MDDs could be partly due to endocrine
dysfunction, which is suspected to play a key role in anxiety/
depressive disorders. In fact,80%of severely depressed patients
exhibit chronic hyperactivity of the hypothalamic-pituitary-
adrenal (HPA) axis, mainly reflected by an excess of plasma cor-
tisol (Anacker et al., 2011). This phenomenon is modeled in
rodents, which show HPA axis abnormalities and increased cor-
ticosterone (CORT) levels upon unpredictable chronic mild
stress, early life stress, or chronic social stress (Lehmann et al.,
2013). Both the hippocampus and the olfactory bulb (OB) are
densely populated with receptors for glucocorticoids (Morimoto
et al., 1996). Although the effects of glucocorticoids in the adult
OB remain relatively unknown, they play an important role in the
hippocampus by negatively regulating the HPA axis, resulting in
stress resilience. In conditions of chronic stress, when there is a
sustained overproduction of glucocorticoids, this inhibitory
feedback is impaired, creating a cascade of hippocampal dam-
age and resulting in maladaptive stress responses (Selye, 1950;
Mirescu and Gould, 2006).
Abundant evidence suggests that chronic stress is highly reg-
ulated by adult hippocampal neurogenesis (Dranovsky and Hen,
2006). In rodents, adult neurogenesis is a key mechanism to
maintain plasticity in response to both internal and environmen-
tal challenges (Lledo et al., 2006), and its functional relevance
ranges from perceptive to cognitive functions, including mood
regulation, pattern separation, learning,memory, and behavioral
responses to olfactory cues (Breton-Provencher et al., 2009; Laza-
rini and Lledo, 2011; Alonso et al., 2012). Abnormal hippocam-
pal neurogenesis is likely to participate in psychiatric disorders,
such as depression (Sahay andHen, 2007), and the production of
adult-born hippocampal neurons is influenced by stress and glu-
cocorticoids (Murray et al., 2008; David et al., 2009; Snyder et al.,
2011). In MDD patients and mouse models of chronic stress,
there is evidence for reduced hippocampal volume and impaired
adult neurogenesis, both of which can be restored by antidepres-
sant treatments (Campbell et al., 2004; Boldrini et al., 2009).
Moreover, adult hippocampal neurogenesis is required for the
response to antidepressants (Santarelli et al., 2003; David et al.,
2009), and adult-born neurons are essential in restoring hip-
pocampal inhibitory control over the HPA axis and in normaliz-
ing glucocorticoid levels following chronic stress (Snyder et al.,
2011).
In this work, we determine whether such a link could be also
drawn between HPA axis dysfunction and olfactory neurogen-
esis. In rodents, newborn neurons from the lateral wall of the
subventricular zone (SVZ)migrate en route to theOB,where they
differentiate into bulbar interneurons. The few existing studies
on the impact of chronic stress on olfactory neurogenesis show
mixed results. While prolonged mild stress or CORT treatment
has been shown to decrease cell proliferation in the SVZ (Hitoshi
et al., 2007; Lau et al., 2011), there is contradictory evidence that
the latter is not sensitive to repeated stress (Chen et al., 2006;
Surget et al., 2008). Nevertheless, clinical studies have reported
that adults with a history of childhood stress or MDD can have
reduced OB volume (Negoias et al., 2010; Croy et al., 2013),
suggesting a potential impact of chronic stress on OB
functioning.
To investigate whether defects in the HPA axis could alter
olfactory neurogenesis and olfaction, we used a neuroendocrine
mouse model of anxiety/depression (David et al., 2009). We
found that chronic CORT affects adult neurogenesis and induces
both anxiety/depression-like states and olfactory impairments.
We then report that coadministration of the antidepressant flu-
oxetine (FLX), a selective serotonin reuptake inhibitor, restores
adult neurogenesis and attenuates the olfactory deficits.
Materials andMethods
Subjects
Experiments were performed using adult male C57BL/6Ntac mice (8
weeks old, 20–25 g), purchased from Taconic Farms. They were housed
in groups of five and maintained in standard conditions (controlled
room temperature and humidity, 12 h light/dark cycle, with lights on at
8:00 A.M., ad libitum access to dry food pellets and water) at the Pasteur
Institute animal care facility, officially registered for experimental studies
on rodents (approval number for animal care facilities: A 75-15-01-6
2014-720). These studies were performed in compliance with the French
legislation (Decree of Feb 1, 2013, 2013-118) and the EuropeanCommu-
nities Council Directive of Sept 22, 2010 (2010/63/EEC). Experimental
designs and procedures were approved by the local ethics committee (no.
2011-0020, CETEA 59 and no. 2013-0081, CETEA 89).
Drugs
The dose of CORT and FLX treatments was selected upon previous stud-
ies (David et al., 2009). CORT (4-pregnen-11b-diol-3 20-dione 21-
hemisuccinate, from Sigma-Aldrich) was dissolved in its vehicle (0.45%
hydroxypropyl--cyclodextrin,-CD, Sigma-Aldrich) andwas available
ad libitum in drinking water (35 g/ml/d, equivalent to 5 mg/kg/d).
FLX (Anawa Trading, 18 mg/kg/d) was delivered either with the vehicle
or withCORT.During the period of water restriction, CORTwas admin-
istered intraperitoneally (i.p.) as previously described (Harris et al.,
2011).
Design and treatment groups
Mice were divided in a total of 11 treatment groups (total n  105) for
four separate experimental sets.
Experimental set 1. Impact of CORT and FLX on behavior, olfaction
and adult neurogenesis (Figs. 1, 2, 4– 6). One group received the vehicle
(n 12) for 20 weeks and the second group received CORT (n 20) for
20 weeks. The third group received CORT during 6 weeks and then
CORTFLX during 14 weeks (n 35). Using standard behavioral tests,
we confirmed the anxious-depressive phenotype of mice at 4 weeks of
CORT treatment (Fig. 1). One test per day was performed in the follow-
ing order: open field, elevated plusmaze, novelty suppressed feeding and
splash test. Then, olfactory tests were conducted at the eighth week of
CORT treatment, using fewer mice in each group (vehicle group: n 8;
CORTgroup:n 8; CORTFLXgroup:n 35). The choice ofmicewas
random and the remaining animals were eliminated from the study.
Following 1 week of training in the olfactometers, olfactory tests lasted 5
weeks (Fig. 3). Olfactory perception was assessed 4 weeks following the
onset of FLX administration. Simple and difficult olfactory discrimina-
tion (carvones and carvone mixtures) was assessed at 6 and 7 weeks,
respectively, following the onset of FLX treatment. Finally, olfactory
memory was assessed at 12 weeks following the onset of FLX treatment.
Allmice (n 51)were subjected to behavioral essays at week 16 of CORT
onset (1 test per day, as follows: open field, elevated plus maze, novelty
suppressed feeding, splash test, tail suspension test, and forced swim test;
Fig. 2) and to an olfactory memory test at week 18 (Fig. 3F ). Immuno-
histochemistry was performed at week 20 using 10 mice from the
CORTFLX group, five mice from the vehicle group and five mice from
the CORT-treated group, that were randomly chosen (see Figs. 5, 6).
Experimental set 2. Impact of chronic FLX on behavior (Fig. 3). One
group received the vehicle (n  10) and the other group received FLX
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(n 10) for 14 weeks (Fig. 3A). Olfactometry was performed following 2
weeks of FLX treatment and lasted 6 weeks. Mice were then subjected to
behavioral analysis at week 10 (1 test per day as follows: open field, elevated
plus maze, novelty suppressed feeding, splash test, tail suspension test and
forced swim test) and to an olfactory memory test at week 12.
Experimental set 3. Impact of CORT on cell proliferation in the olfac-
tory epithelium (see Fig. 7). Immunohistochemistry was done using two
groups of mice, one group that was treated with CORT during 4 weeks
(n 5) and a group that received the vehicle (n 5).
Experimental set 4. Impact of FLX on the morphology of adult-born
OB neurons in CORT-treated and naivemice (see Fig. 8). The first group
(n 4) received the vehicle and the second group (n 4) receivedCORT
during 11 weeks. The third group received CORT during 4 weeks and
then CORTFLX during 7 weeks (n  4). The fourth group (n  4)
received the vehicle during 4weeks and then FLXduring 7weeks (see Fig.
8A). A lentiviral vector was injected in the SVZ at week 8 to label adult
newborn neurons (see Fig. 8C). Immunohistochemistry was performed
at week 11.
Behavioral assessment
A battery of behavioral tests was used for the mice included in experi-
mental sets 1 and 2, to assess locomotor activity, anxiety and depression-
like behavior and olfaction.
Open-field.Animals were placed inwhite Plexiglas containers (43 43
cm2) and their behavior was recorded by a video camera during 30 min.
A tracking system (Noldus Ethovision 3.0) was used to map center and
periphery zones and to calculate the time spent in each zone.
Elevated plus maze. The test was conducted using a plus-cross-shaped
apparatusmade of black Plexiglas that was elevated 58 cm above the floor
and comprised two open and two closed arms (30 6 cm) that extended
from a central platform (7 7 cm). The Noldus Ethovision 3.0 tracking
systemwas used to record behavior for 6min. The time spent and entries
in center, open arm, and closed arm zones were calculated.
Novelty suppressed feeding. The test container used was a white plastic
box (50  50  20 cm) whose floor was covered by wooden bedding.
Twenty-four hours prior testing, all food was removed from the home
cage. A single food pellet (regular chow) was adhered on a piece ofWhat-
man paper and positioned in the center of the container that was brightly
illuminated. The latency to eat wasmeasured during 10min as previously
described (David et al., 2009). At the end of each session, the animals
were immediately transferred into their home cage and the amount of
food consumed over the subsequent 5 min period, as well as their body
weight, were measured as a control of feeding drive.
Splash test. The test consisted in squirting 200 l of a sucrose solu-
tion on the dorsal coat of the mouse, as previously described (Surget et
al., 2008). Grooming latency, frequency, and durationwere assessed dur-
ing 6 min.
Tail suspension test. Mice were suspended by the tail using adhesive
tape on a metal rod of an automated tail suspension apparatus (Bioseb),
as previously described (Cryan et al., 2005). Immobility time and power
of movement were recorded during a 6 min period.
Forced swim test. The test was performed using an automated forced
swim test software (Bioseb), as previously described (Garza et al., 2012).
Total immobility time, swimming, and climbing states were measured
during a 6 min session.
Olfactometry
Mice were partially water-deprived for 1 week and were then trained
using an operant conditioning go/no-go procedure in computer-
controlled olfactometers (Fig. 4A) as described previously (Alonso et al.,
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Figure 1. Chronic CORT treatment induces anxiety and depression-like states. Following 4 weeks of CORT administration, anxiety, and depression-like behaviors were assessed using the open
field, elevated plus maze, novelty suppressed feeding test, and splash test. CORT decreased the time spent (A) in the center of the open field and (B) in the open arms of the elevated plus maze. C,
Graph showing the latency to feed in the novelty suppressed feeding paradigm, presented as the fraction of mice that did not eat over a period of 10 min. D, CORT did not affect feeding drive. E,
CORT-treatedmice displayed an increased latency to groom in the splash test. F, The total number of grooming sessionswithin the 6min trial was significantly decreased by CORT. Values are plotted
as mean SEM (n 12 for vehicle-treated and n 55 for the CORT group). *p 0.05, ***p 0.001 compared with vehicle-treated.
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2012; www.olfacto-meter.com). In this paradigm, mice were trained to
respond to the presence of a rewarded stimulus odorant (S) by licking
thewater delivery tube, and to refrain from responding to the presence of
non-rewarded stimulus odorant (S). A response in an S trial and an
absence of response in an S trial were scored as correct. Accuracy was
scored for each block of 20 trials.Mice were subjected to a daily session of
eight blocks. Monomolecular odorant compounds and binary odorant
mixtures (Sigma-Aldrich), were diluted either in water or in mineral oil
(MO), and 10ml of the resulting solutionwas used as the odorant source.
Olfactometry was performed in the following order: (1) training and
discrimination of isoamyl-acetate (IAA) versusMO (1st and 2ndweeks),
(2) odorant (N-butanol) detection threshold (3rd and 4th weeks), and
(3) carvone and carvone mixture discrimination (5th and 6th weeks).
Olfactorymemorywas assessed in one session following a 4week interval
from the end of the 5th week.
In the odorant detection threshold test, mice were tested for their
ability to detect successively descending decimal concentrations of
N-butanol (S) diluted in water (S), starting with a concentration of
0.01%. The session ceased at the achievement of criterion performance
(75% of correct responses in at least one block). The odorant detection
threshold test ceased when the criterion performance was not achieved
after three successive sessions with the same odorant dilution. The accu-
racy criterion (75% of correct responses in at least 1 block) was used to
calculate odorant detection threshold.
In the odorantmixture discrimination tasks, mice were trained to distin-
guish between two carvone enantiomers diluted in MO: 0.1% carvone
(S) and0.1%carvone (S).Carvonesbelong to the terpenoid family and
are food scents. S-carvone smells like caraway (Carumcarvi) andAnethum
graveolens, whereas S-carvone smells like spearmint. Mammals, including
humans, are able to spontaneously discriminate between the two carvone
enantiomers (Linster et al., 2002). Mice were then tested in two discrimina-
tion tasks including carvonemixtures. In the first task, Swas attributed to
a solutionof80%carvone and20%carvone, andS toa solutionof20%
carvone and 80% carvone. In the second task, the S odorant was a
solutionof 60%carvone and40%carvone, whereas Swas a solutionof
40% carvone and 60% carvone.
For the olfactory memory task, mice underwent eight blocks of 20
trials every day for 5 consecutive days, to recall distinguishing between
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Figure 2. Effects of FLX on CORT-induced anxiety- and depression-like states. A, Diagram depicting experimental groups and study design. Animals were tested in the open field, elevated plus
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carvone and carvone. Then, mice were tested on the same task after a
rest period of 4 weeks, in one block of 20 trials, but with no reward given
for a correct response.
Bromodeoxyuridine injections. Mice were intraperitoneally injected
with a DNA synthesis marker, bromodeoxyuridine (BrdU; 100 mg/kg,
Sigma-Aldrich). They received one injection 2 h before perfusion for the
analysis of cell proliferation, or four injections, at 2 h intervals, on a single
day, 4 weeks before perfusion, for the analysis of cell survival.
Stereotaxic lentiviral injections
To study the morphology of adult-born neurons, a replication-deficient
lentiviral vector expressing green fluorescent protein (GFP) under con-
trol of the cytomegalovirus (CMV)promoter (LV-CMV-GFPwith a viral
titer of 109 units/ml) was used as previously described (Lazarini et al.,
2014). The concentration of lentiviral vector particles used for injection
was 13.8 ng of viral antigen per microliter assayed by ELISA (1010
transduction units per milliliter). The LV-CMV-GFP vector was pre-
pared at the ENP vector platform (www.paris-neuroscience.fr). Mice
were deeply anesthetized by a mixture of ketamine and xylazine (100
mg/kg ketamine, 16 mg/kg xylazine). Small craniotomies were per-
formed above the injection sites using a dentist drill. We performed
bilateral virus injections (200 nl per site) into the rostral migratory
stream (RMS) at 3.30 mm anteroposterior and 0.82 mm mediolat-
eral from bregma, and 2.90 mm dorsoventral from skull surface, to
label SVZ-generated neuroblasts that migrate toward the OB. Mice were
then transferred to their home cage for recovery.
Immunohistochemistry
Mice were deeply anesthetized with sodium pentobarbital (i.p., 100 mg/
kg, Sanofi) and perfused transcardially with a solution containing 0.9%
NaCl and heparin (5 103 U/ml, Sanofi-Synthelabo) at 37°C, followed
by 4%paraformaldehyde in phosphate buffer, pH7.3.Olfactory epithelia
(OE) and brains were removed and postfixed by incubation in the same
fixative at 4°C overnight. OE were cryoprotected by incubation in 30%
sucrose in PBS for 24 h, and then embedded in Tissue-tek (Sakura). OE
20-m-thick coronal sections were obtained using a cryostat (CM3050S,
Leica) and were thaw-mounted onto coated glass slides (Superfrost
Plus). Forty-micrometer-thick coronal brain sections were obtained us-
ing a vibrating microtome (VT1000S, Leica). In the experiments using
viral labeling of neuroblasts, 60-m-thick coronal sections were pre-
pared. Immunostaining was performed on free-floating sections for
brain slices and fixed sections for OE. Nonspecific staining was blocked
by 0.2%Triton, 4%bovine serum albumin (Sigma-Aldrich) and 2%goat
serum. Slices were first incubated with primary antibodies at 4°C
overnight, and then with secondary antibodies (biotinylated or Ale-
xaFluor-conjugated secondary antibodies, Jackson ImmunoResearch
Laboratories) at room temperature. Primary antibodies used in this
study and their working dilutions are listed in Table 1.
For doublecortin (DCX) immunolabeling, brain sections were prein-
cubated in citrate buffer (10 mM, pH 9.0) at 80°C for 20 min. For Ki67
immunostaining, OE sections were preincubated in citrate buffer (10
mM, pH 6.0) at 80°C for 20 min. For BrdU staining, DNA was denatured
with 2N HCl at 37°C for 30 min. Fluorescent sections were stained with
the nuclear dye 4	,6	-diamidino-2-phenylindole (DAPI) and then
mounted in a solution of 1,4-diazabicyclo [2.2.2] octano (Sigma-
Aldrich). Immunoperoxidase-labeled cells were detected with a per-
oxidase-conjugated secondary antibody (ABC system, Vector Laborato-
ries), using biotinylated donkey anti-rat, goat anti-rabbit or horse anti-
goat IgG (1:200, Vector Laboratories) and 3,39-diaminobenzidine
(0.05%) as a chromogen (Sigma-Aldrich).
For morphologic analysis of adult-born neurons in the OB, the label-
ing was enhanced with a GFP immunostaining (rabbit anti-GFP primary
antibody, 1/1000, and goat anti-rabbit second antibody, 1/500, Invitro-
gen). DAPI (1/5000) was used as a nuclear stain.
Image acquisition and quantification analysis
Immunofluorescence was analyzed using a confocal laser-scanning mi-
croscope (LSM 710; Zeiss) with Zen Imaging software (Zeiss) and a
confocal spinning disk Cell Voyager (CV1000, Yokogawa). For the anal-
ysis of immunoperoxidase-labeled cells, reconstructed images of the
dentate gyrus (DG), SVZ, and OB were taken using an Olympus BX51
microscope (20 objective) and the Compix Imaging software
(Hamamatsu Photonics).
Quantification was performed using the Icy open source platform
(http://www.icy.bioimageanalysis.org; Olivo-Marin, 2002; de Chau-
mont et al., 2012). The internal and external borders of the RMS, the
glomerular layer (GL), and granule cell layer (GCL) of the OB were
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delineated and DCX and BrdU cells were counted manually using
the plugin “Manual counting” (http://icy.bioimageanalysis.org/plugin/
manual_counting). Regions-of-interest were designed with the ring pl-
ugin (http://icy.bioimageanalysis.org/plugin/Ring ROI). Values are ex-
pressed as the mean of total DCX or BrdU cell count in six OB slices
per animal.
For the quantification of DCX immunoreactivity (IR) in the SVZ and
olfactory marker protein (OMP) IR in glomeruli of the OB, pixel density
was computed using the plugin “Thresholded pixel density.” This plugin
computes the number of pixels over a threshold in a given region of
interest over the total number of pixels present in the region of interest
(http://icy.bioimageanalysis.org/plugin/Thresholded_pixel_density). For OMP
Table 1. Detailed information on the primary antibodies used in this study
Antibody Manufacturer Marker
Working
dilutions
BrdU Abcys, ABC 117-7513 Proliferating cells 1:1000
DCX Abcam, ab 18723 Neuroblasts 0.5g/ml
GFP Molecular Probes LV-CMV-GFP 1:1000
Ki67 Abcam, ab16667 Proliferating cells 1:500
NeuN Millipore Bioscience Research Reagents, Neurons 5g/ml
OMP MAB377 Olfactory sensory neurons 1:2000
Wako, 544-10001
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IR, six glomeruli of the dorsomedial part of OB coronal sections were
selected and assessed for each animal. The batch mode of this analysis is
available as a protocol [http://icy.bioimageanalysis.org/protocol/Pix- el-
_density_(batch_mode)]. All the codes and implementation of these
programs are available online. For the quantification ofKi67 cells in the
OE, serial sections of the olfactory mucosa situated through the anterior
end of the OB were analyzed blindly. Four to six serial sections were
chosen per animal (5 animals analyzed per group, 6–7 zones analyzed per
OE section).
For hippocampal analysis, values are expressed as themean total num-
ber of DCX or BrdU cells counted manually in 8 DG sections per
animal. For BrdU and neuronal nuclei (NeuN) double-staining analysis,
positive cells were counted in the GCL (6 slices per animal, 4 mice ana-
lyzed per group, 80–120 BrdU cells analyzed) and in the DG (8 slices
per animal, 4 mice analyzed per group, 20–30 BrdU cells analyzed).
Data are expressed as the number of double-labeled cells in the GCL
and DG.
For the analysis of dendritic morphology of adult newborn OB neu-
rons, 8 coronal sections of a 180 m distance were selected, taking the
accessory OB as a landmark. Fifteen neurons (located 40 m in the
GCL) were selected for each animal. These neurons were imaged using a
confocal microscope (Zeiss LSM 700, 25 objective, 0.5–1 numerical
zoom). The dendritic tree was manually traced using the Filament tracer
module of the Imaris Bitplane software v7.6. Total dendritic length,
number of branches and Sholl data were collected. For Sholl analysis,
virtual concentric circles were traced at every micrometer starting from
the beginning of the dendrite, and the number of intersections between
the dendritic tree and each circle were counted as previously described
(Pallotto et al., 2012). For the analysis of dendritic morphology of hip-
pocampal adult-born neurons, the maturation index was calculated as
previously described (Mendez-David et al., 2014). DCX cells were sub-
categorized according to their dendritic morphology as DCX cells
without and DCX cells with tertiary (or higher order) dendrites. The
maturation index was defined as the ratio of DCX cells possessing
tertiary dendrites to the total number of DCX cells.
Statistical analysis
All data were expressed as mean  SEM. Statistical analyses were
performed using the Prism software (GraphPad v6), with p  0.05
considered statistically significant. Data were analyzed using un-
paired two-tailed Student’s t test, one-way ANOVA or two-way
ANOVA followed by Bonferroni post hoc test or Mantel-Cox log-rank
test when appropriate.
Results
Chronic CORT treatment induces anxiety- and depression-
like states in mice
Using standard tests for anxiety and depression, we confirmed
that chronic treatment with CORT triggers an anxiety/
depression-like phenotype that is responsive to chronic FLX
treatment. At 4 weeks of treatment, CORT decreased the time
spent in the center of the open field (185 12 s vs 333 43 s, t
4.53, p 0.001, unpaired t test; Fig. 1A), and in the open arms of
the elevated plus maze (39 3 s vs 58 11 s, t 2.19, p 0.03,
unpaired t test; Fig. 1B). In the novelty suppressed feeding test,
CORT significantly increased feeding latency (359 23 s vs 97
12 s, p 0.001, Kaplan–Meier survival analysis, Mantel-Cox log-
rank test; Fig. 1C) without affecting feeding drive (Fig. 1D),
whereas in the splash test CORT increased grooming latency
(207  17 s vs 55  12 s, p  0.001, Kaplan–Meier survival
analysis, Mantel-Cox log-rank test; Fig. 1E) and decreased
grooming frequency (2  0.2 vs 5  0.8, t  4.78, p  0.001,
unpaired t test; Fig. 1F).
At 16–17 weeks of CORT treatment (Fig. 2A), feeding latency
in the novelty suppressed test remained significantly increased
(470  52 s vs 80  15 s, p  0.001, Kaplan–Meier survival
analysis, Mantel-Cox log-rank test; Fig. 2B) without changes in
feeding drive (vehicle: 0.29  0.05; CORT: 0.25  0.06;
CORTFLX: 0.23  0.07; F(2,44)  0.19, p  0.1, one-way
ANOVA, Bonferroni post hoc test; Fig. 2C).Moreover, changes in
grooming behavior persisted, namely decreased grooming fre-
quency (3  0.3 vs 6  0.7; F(2,44)  7.09, p  0.03, one-way
ANOVA, Bonferroni post hoc test; Fig. 2D) and increased latency
to groom (116  18 s vs 29  7 s, p  0.001; Kaplan–Meier
survival analysis, Mantel-Cox log-rank test; Fig. 2E). CORT also
increased immobility in the forced swim test (119 18 s vs 230
37 s; F(2,44) 4.13, p 0.02, one-way ANOVA, Bonferroni post
hoc test; Fig. 2F) and in the tail suspension test, albeit in a non-
significant manner (Fig. 2G). Chronic FLX exerted anti-
depressant effects that were mainly prominent in the novelty
suppressed feeding and splash tests. More specifically, FLX re-
stored feeding latency (176 34 s, p 0.001 vs CORT, one-way
ANOVA, Bonferroni post hoc test), as well as grooming frequency
(6 0.5, p 0.002 vs CORT, one-way ANOVA, Bonferroni post
hoc test) and latency to groom (27  4 s, p  0.001 vs CORT,
Kaplan–Meier survival analysis, Mantel-Cox log-rank test; Fig.
2B,D,E). When administered alone for 10–11 weeks (Fig. 3A),
chronic FLX generated some anxiety-related behaviors in other-
wise naivemice, reflectedmainly by an increase in feeding latency
in the novelty suppressed feeding test (vehicle: 81  13 s; FLX:
212 42 s, t 3.3, p 0.005, unpaired t test; Fig. 3B). Together,
these data indicate that chronic CORT exposure induces an
anxiety/depression-like state in mice that is reversed by pro-
longed coadministration of FLX.
Olfactory discrimination is impaired by chronic CORT and
not restored by FLX
To test whether the observed anxiety/depression-like state was ac-
companiedbyolfactorydeficits,we first evaluatedolfactorydiscrim-
ination by using an automated operant conditioning procedure (a
go/no-go test; Fig. 4A). Mice were trained to recognize IAA as the
stimulus rewarded with water (S) and MO as the non-rewarded
stimulus (S; Fig. 4B). In the next step, mice were trained to distin-
guish between two carvone enantiomers diluted in MO; carvone
(S) and carvone (S); and we then assessed fine olfactory dis-
criminationusing binarymixtures of the same carvone enantiomers
(Fig. 4C). We observed that CORT and CORTFLX did not affect
acquisitionandsuccess rates in the simplediscrimination taskof IAA
versus MO and in the carvone enantiomer task (Fig. 4B,C). How-
ever, in the “difficult”mixture discrimination task, the performance
of CORT-treated animals was significantly poorer compared with
controls and was not restored by FLX (two-way repeated mesures
ANOVA, 8/2mixture ratio task: treatment factor F(2,44) 5.04, p
0.01; 6/4mixture ratio task: treatment factorF(2.44) 5.43, p 0.01;
Fig. 4C).
Olfactory acuity is impaired by chronic CORT and restored
by FLX
Mice were trained to detect successively descending decimal con-
centrations of N-butanol (S) diluted in water (S), starting
with a concentration of 0.01%. CORT decreased the detection
threshold by two orders of magnitude (Fig. 4D; mean odorant
dilution (log); vehicle: 8.2  0.4; CORT: 6.5  0.3; F(2.44) 
4.23, p 0.02, one-way ANOVA, Bonferroni post hoc test). Co-
treatment with FLX attenuated the CORT-induced deficit (Fig.
4D; mean odorant dilution (log); 7.7 0.3, p 0.03, one-way
ANOVA, Bonferroni post hoc test).
524 • J. Neurosci., January 13, 2016 • 36(2):518–531 Siopi et al. • Olfactory Deficits in Depression
Olfactory memory is affected by chronic CORT and improved
by FLX
We assessed long-term olfactory memory by using the same pair
of carvone isoforms (Fig. 4E). Thirty days following task consol-
idation, the ability of mice to recognize carvone and carvone
enantiomers was re-evaluated, using one block of 20 trials that
was devoid of water reward. Four weeks following task consoli-
dation, the performance of CORT-treated mice was near chance
level, revealing that chronic CORT impaired olfactory memory
[mean correct response; vehicle: 72.5%; CORT: 50.6%; p 
0.002, two-way ANOVA; F(2.44) (treatmentmemory) 7.22].
Treatment with FLX was able to improve performance (mean
correct response; 61.3%, p 0.05 compared with CORT).
Olfaction is impaired by chronic FLX
Although FLX restoredmost CORT-induced olfactory deficits, it
significantly impaired olfaction when administered alone chron-
ically (Fig. 3C–F). FLX induced a substantial decrease in olfactory
acuity [mean odorant dilution (log); vehicle: 6.5 0.2; CORT:
4.1 0.8; t 3.28, df 16, p 0.003, unpaired t test; Fig. 3C].
Fine discrimination was also affected (Fig. 3D,E), and this effect
was most prominent in the 6/4 versus 4/6 carvone mixture task
(two-way ANOVA; F(1,16) treatment  8.59, p  0.01; Fig. 3E).
Long-term olfactory memory was also significantly impaired by
FLX (two-way ANOVA; F(1,32) interaction  16.45, p  0.003;
Fig. 3F).
Adult neurogenesis is impaired by chronic CORT and
restored by chronic FLX
We then investigated whether adult neurogenesis was affected by
CORT. We measured the production of new neurons in the SVZ
and DG and their survival rate in the OB and DG. Quantitative
analysis of the population of adult-born neurons at 20 weeks of
CORT and 14 weeks of CORTFLX treatment showed a signif-
icant twofold decrease in the number of DCX neurons in the
DG that was reversed by FLX (mean cell number; vehicle: 4782
115; CORT: 1879 286; CORTFLX: 7439 910 cells; F(2.18)
7.06; CORT vs vehicle: p  0.04; CORT vs CORTFLX: p 
0.002; one-way ANOVA, Bonferroni post hoc test; Fig. 5A,D). On
the other hand, neither CORTnor CORTFLX altered the num-
ber of DCX in the SVZ (Fig. 5B,F). These results indicate that
CORT affects differentially the two stem cell niches of the adult
brain, reducing neural production in the DG but sparing SVZ
neurogenesis. Yet, we found that the number of DCX neurons
in the core of the OB, the RMSob, was decreased in the CORT
group, and this effect was reversed by FLX (vehicle: 15,834 
1049; CORT: 10,316  310; CORTFLX: 15,590  1332 cells;
F(2.18) 5.78; CORT vs vehicle: p 0.04; CORT vs CORTFLX:
p 0.03, one-way ANOVA, Bonferroni post hoc test; Fig. 5C,H).
Moreover, the number of DCX cells was notably reduced by
CORT and restored by FLX in the GCL (vehicle: 29,292 1159;
CORT: 15,876 355; CORTFLX: 29,545 4557 cells; F(2.18)
4.02; CORTvs vehicle: p 0.05; CORTvsCORTFLX: p 0.05,
one-way ANOVA, Bonferroni post hoc test; Fig. 5C,G) and in the
GL (vehicle: 2491  64; CORT: 1387  158; CORTFLX:
2476 282; F(2.18) 5.72; CORT vs vehicle: p 0.04; CORT vs
CORTFLX: p  0.03, one-way ANOVA, Bonferroni post hoc
test; Fig. 5I). Therefore, it is likely that CORT affects olfactory
adult neurogenesis by altering neuronal survival in the OB, while
leaving intact cell production in the SVZ.
To address this questionmore directly, we examined both cell
proliferation and survival in the DG and OB, by measuring
BrdU cells 2 h and 1 month following BrdU injection, respec-
tively (Fig. 6A). BrdU cell counting confirmed that CORT sig-
nificantly decreases cell proliferation in the DG, whereas FLX
completely restores it (mean BrdU cell number; vehicle: 723
60; CORT: 414 58; CORTFLX: 985 126 cells; F(2.18) 5.76;
CORT vs vehicle: p  0.05; CORT vs CORTFLX: p  0.02,
one-way ANOVA, Bonferroni post hoc test; Fig. 6B,F). However,
neither CORT nor CORTFLX altered the number of BrdU in
the SVZ (Fig. 6G).
Moreover, CORT induced a twofold decrease in the survival
of newborn cells in the DG (BrdU cell number; vehicle: 361
30; CORT: 207 29; F(2.18) 0.58, p 0.02, one-way ANOVA,
Bonferroni post hoc test; Fig. 6H). FLX reversed this effect albeit
in a nonsignificantmanner. Likewise, cell survival was reduced by
CORT in the OB, both in the GL (BrdU cell number; vehicle:
997  123 cells; CORT: 523  60 cells; F(2.18)  1.17, p  0.05,
one-way ANOVA, Bonferroni post hoc test; Fig. 6I) and the GCL
(BrdU cell number; vehicle: 9082 1212 cells; CORT: 4978
475 cells; F(2.18) 4.91, p 0.02, one-way ANOVA, Bonferroni
post hoc test; Fig. 6J). FLX reversed this effect mainly in the GL
(BrdU cell number, 985  101 cells, p  0.03 vs CORT; one-
way ANOVA, Bonferroni post hoc test). Finally, BrdU and NeuN
colabeling showed that the vast majority of BrdU cells were also
colabeled with the neuronal biomarker NeuN in all treatment
groups tested (Fig. 6E,K). In the GCL of OB, analysis of 80–120
cells per animal (n  4 mice) in the vehicle group showed that
90% BrdU cells coexpressed NeuN and thus had a neuronal
phenotype. We found that the percentage of BrdU cells labeled
with NeuN was not modified by CORT and CORTFLX treat-
ment (Fig. 6K; vehicle: 92.5  1.5%; CORT: 92.8  0.9%;
CORTFLX: 91.1  0.6%). Moreover, we found no group dif-
ference inBrdU/NeuNdouble staining in theDG (20–30 cells per
animal; vehicle: 91.1 0.5%; CORT: 87.7 3.1%; CORTFLX:
91.8  0.7%). Together, these data indicate that chronic CORT
exposure affects both adult hippocampal and olfactory neuro-
genesis and that chronic FLX can stimulate the recruitment
and/or survival of newborn neurons within the DG and OB.
Chronic CORT treatment does not alter adult neurogenesis in
the olfactory epithelium
Given the prominent effects of CORT on olfactory function, we
checked whether the olfactory sensory organ could be impaired.
Olfactory sensory neurons located in theOE project via the olfac-
tory nerve to glomeruli in the GL of the OB, where they synapse
on the dendrites of output mitral/tufted cells. Olfactory sensory
neurons are continually replaced throughout life by the progeny
of dividing basal cells located in theOE.We quantified the level of
cell proliferation in the OE by counting the number of Ki67
cells in this zone. Anti-Ki67 immunostaining is mainly localized
in the basal area of the normal OE (Fig. 7A,B). We found no
difference in the distribution and the number of Ki67 cells be-
tween vehicle and CORT-treatedmice following 4 weeks of treat-
ment [mean number of Ki67 cells (104) per mm3; vehicle:
8.09 0.23; CORT: 8.55 0.65, unpaired t test; Fig. 7C]. Stain-
ing for OMP, a cell marker specific of mature olfactory sensory
neurons, was quantified in the GL (Fig. 7E). We found no differ-
ence in the distribution and intensity of OMP between vehicle,
CORT and CORTFLX-treated mice (mean IR within glomer-
uli; vehicle: 0.1498 0.02; CORT: 0.1803 0.01; CORTFLX:
0.1503  0.01; one-way ANOVA, Bonferroni post hoc test; Fig.
7F). These results indicate that cell proliferation in the OE and
the degree of sensory innervation in theOBare both insensitive to
chronic CORT treatment.
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Impact of CORT and FLX on the morphology of newborn
interneurons
Dendritic complexity of adult-bornDGneurons increases during
the first month following neuronal birth, a stage during which
cells express the DCX marker. To further examine the effects of
CORT on dendritic morphology of newborn neurons, we char-
acterized DCX cells in the DG according to the number of
dendrites, and calculated the maturation index as the ratio of
DCX cells with tertiary (or higher order) dendrites to the total
number of DCX cells. Although we found no effect of chronic
CORT on the maturation index of adult-born DG neuroblasts,
we observed a significant threefold increase induced by
CORTFLX (mean maturation index; vehicle: 0.20  0.02;
CORT: 0.21  0.03; CORTFLX: 0.55  0.09; F(2.12) 
0.89; CORT vs CORT  FLX: p  0.007, one-way ANOVA,
Bonferonni post hoc test; Fig. 5E).
DCX is also expressed by adult-bornOB interneurons for10
d after birth but cannot be used for the assessment of dendrite
complexity due to the large staining in the OB. Thus, to assess the
impact of chronic CORT and FLX on thematuration of newborn
OB interneurons, a lentiviral vector expressing the GFP was in-
jected into the RMS following 8 weeks of CORT and 4 weeks of
CORTFLX or FLX alone (Fig. 8A,C). Three weeks after injec-
tion, we analyzed the apical dendritic tree of GFP adult-born
granule cells in the OB and found that chronic CORT did not
alter the number of dendrites (Fig. 8D) nor total dendritic length
(Fig. 8E). However, CORTFLX and FLX alone increased both
the number of dendrites (vehicle: 4.93  0.29; CORT: 4.92 
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0.25; CORTFLX: 5.66 0.36; FLX: 5.84 0.34; F(3.16) 0.46;
vehicle vs FLX: p 0.05; one-way ANOVA, Bonferroni post hoc
test) and dendritic length (vehicle: 559.8  28.2 m; CORT:
586.4  24.3; CORTFLX: 714.7  24.3; FLX: 659.8  25.7;
F(3.16) 6.76; vehicle vs CORTFLX: p 0.001; vehicle vs FLX:
p  0.05; CORT vs CORTFLX: p  0.01; one-way ANOVA,
Bonferroni post hoc test; Fig. 8D,E). Sholl analysis revealed that
the most significant changes in the number of branches were
obtained by CORTFLX, suggesting a cumulative effect of the
two treatments (two-way ANOVA; F(3,155) 7.36, p 0.001; Fig.
8F). Finally, we observed no effect of CORT and FLX on spine
density and length (data not shown). Together, these results sug-
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gest that FLX, but not CORT, facilitates the maturation of new-
born neurons in both the adult hippocampus and OB circuits.
Discussion
This study reports that a mousemodel that mimics states of HPA
axis hyperactivity, a common trait of MDD, is associated with
impaired adult neurogenesis and pronounced olfactory deficits,
including acuity, discrimination, and memory. We found that
prolonged antidepressant treatment with fluoxetine not only re-
stored adult neurogenesis and mood, but also improved most
olfactory functions. Our data identify a key role for the HPA axis
in olfactory impairments associated with anxiety/depressive
states.
Deleterious impact of chronic CORT on adult neurogenesis
and olfaction
Our present findings demonstrate that the CORTmodel not only
evokes a persistent fear-related response inhibition, reminiscent
of anxiety/depression-like states, but also induces olfactory dys-
function. Importantly, similar olfactory deficits affecting odorant
detection and discrimination have been reported in MDDs
(Pause et al., 2001; Negoias et al., 2010). In turn, perturbations of
the olfactory circuit and function can induce anxiety and
depression-like behaviors in rodents (Glinka et al., 2012; Lazarini
et al., 2012). Thus, we cannot rule out the possibility that CORT-
induced olfactory deficits could be in part responsible for the
mood states observed in this model. For instance, olfactory bul-
bectomy constitutes a model of depression and is used as a pre-
dictor of antidepressant drug response in rodents (Wren et al.,
1977). Although the precisemechanisms remain elusive, it can be
speculated that such sensory deficits likely affect the function of
neural circuits involved in the control of mood and emotions.
Interestingly, we also found that chronic CORT significantly
reduces neurogenesis in the OB. The number of new OB in-
terneurons was decreased twofold following CORT treatment in
all OB layers. This decrease could partly explain the CORT-
induced olfactory deficits, because adult-born OB interneurons
take part in odorant detection, discrimination, olfactory learn-
ing, and memory (Breton-Provencher et al., 2009; Moreno et al.,
2009; Mouret et al., 2009; Belnoue et al., 2011; Lazarini et al.,
2011; Alonso et al., 2012; Sakamoto et al., 2014). However, it is
important to note that in humans, MDD-related hyposmia is
unlikely to be due to reduced neurogenesis in the OB, as cells
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born in the adult SVZ aremostly directed to the striatum and not
to the OB (Ernst et al., 2014). Moreover, one cannot rule out the
possibility that the CORT-induced hyposmia revealed in this
study could be partly linked to a deleterious effect of CORT on
preexisting granule and periglomerular cells in the OB. This
could also be the case in human patients suffering from MDD.
Finally, because glucocorticoid receptors are widely distributed
in the OB and olfactory cortex, as in other limbic areas, notably
the hippocampus, amygdala, and hypothalamus (Morimoto et
al., 1996), it is possible that CORT-induced changes in overall
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cortical and limbic processing could be linked to the observed
olfactory deficits.
Our results also showed that chronic CORT impairs both pro-
liferation and survival of progenitor cells in the DG, demonstrat-
ing a role for glucocorticoids in several steps of the neurogenic
process. Our data are in line with previous work reporting that
ablation of the adrenal glands abolishes the stress-induced de-
crease in cell proliferation in the DG (Tanapat et al., 2001). Al-
though CORT reduced cell proliferation in the DG, it did not
affect cell proliferation in the OE nor the number of newly gen-
erated immature neurons expressing DCX in the SVZ. Our re-
sults indicate that the early steps of adult neurogenesis are
differentially regulated by CORT in the DG, EO, and SVZ. How-
ever, given the decrease in the population of adult-born neurons
in the OB, it is possible that CORT treatment alters the survival
rate of adult-born OB neurons. Interestingly, their dendritic
morphology was not changed by CORT, suggesting that the sur-
viving neurons are functionally integrated in the OB circuit. This
hypothesis is also supported by the fact that the distribution and
degree of the sensory afferents reaching the OB, was unchanged.
Concerning the adult olfactory system, the functional impor-
tance of CORT remains largely unknown. New experiments aim-
ing to assess firing activity, dendritic dynamics, and innate
responses to odorants are needed to decipher the precise role of
CORT in olfactory processing and odor-driven behaviors.
Chronic FLX treatment attenuates CORT-induced olfactory
deficits and restores adult neurogenesis
Our findings show that the antidepressant FLX can restore olfac-
tory acuity andmemory in CORT-treatedmice. Interestingly, we
also showed that FLX restores olfactory neurogenesis and facili-
tates the maturation of adult-born neurons in the OB and hip-
pocampus. This proneurogenic effect could partly support the
FLX-induced restoration of olfactory deficits. Similarly, recruit-
ment of newborn neurons was recently reported to selectively
restore circuits in the lesionedOB and resume olfaction (Lazarini
et al., 2014).
FLX restored both proliferation and survival of progenitor
cells in the DG, as previously reported (David et al., 2009; Rainer
et al., 2012; Guilloux et al., 2013). By restoring hippocampal neu-
rogenesis, FLX probably helps reestablish HPA axis function, re-
sulting in functional improvement. In fact, it is argued that newly
generated neuronsmay facilitate a dysfunctional hippocampus to
restore control on stress response systems, and that the ability of
FLX to restore hippocampal regulation of the HPA axis under
chronic stress occurs only in the presence of an intact neurogenic
niche. Further experiments aiming to selectively block either DG
or SVZ neurogenesis in our model are required to disambiguate
the role of each site of adult neurogenesis in the response to FLX
and their associated behavioral rehabilitation.
Finally, to explain the olfactory deficits induced by FLX alone,
one should keep in mind that the OB is one of the most densely
innervated serotonergic targets of the raphe nuclei, and fibers
from the latter are the densest centrifugal projections in the OB
(Dugue´ and Mainen, 2009). Serotonin alters synaptic transmis-
sion and information processing in the glomerular layer of the
OB, where the density of serotonergic fibers from the raphe nu-
clei is maximal. As it has been indicated by early experiments,
local application of serotonin receptor agonists attenuates odor-
evoked olfactory neuron activity (Bloom et al., 1964), whereas
serotonin receptor antagonists boost glomerular activation,
showing that endogenous serotonin suppresses odor input (Pet-
zold et al., 2009). These previous studies could explain the deficits
in olfactory acuity, discrimination, and long-term memory ob-
tained by chronic FLX treatment.
Together, our findings introduce novel effects of chronic
CORT and FLX on olfaction and olfactory neurogenesis in the
mouse. These observations bring further insights on the poorly
known biological underpinnings of anxiodepressive states and
help move towardmore effective therapeutic ends targeting neu-
rogenesis, as well as useful diagnostic tools based on olfaction.
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